Marshall E. Reese
Keine laufenden Positionen mehr
Profil
Marshall E.
Reese joined POZEN, Inc. in October 2004 and served as Executive Vice President of Product Development until March 2009.
Dr. Reese was Senior Vice President and Global Head of Research and Development and Consumer Health Care for Novartis.
Prior to joining Novartis in 1999, he held various senior executive positions at Glaxo, Inc. and GlaxoWellcome.
Dr. Reese was Vice President of Global OTC Development and Manufacturing for GlaxoWellcome.
He was Vice President of Development Planning and International OTC Strategies for Glaxo and GlaxoWellcome.
He received a BS, an MS and a PhD from the University of Tennessee at Knoxville.
Ehemalige bekannte Positionen von Marshall E. Reese
| Unternehmen | Position | Ende |
|---|---|---|
| POZEN INC. | Corporate Officer/Principal | 31.03.2009 |
| NOVARTIS AG | Corporate Officer/Principal | 01.01.2004 |
| Glaxo Wellcome Plc | Corporate Officer/Principal | - |
| Glaxo, Inc. | Corporate Officer/Principal | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Ausbildung von Marshall E. Reese
| University of Tennessee | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| Glaxo, Inc. | |
| Glaxo Wellcome Plc | Health Technology |
